| 标题 |
Should Only Patients with BRCA Mutation Be Treated with a Combination of an Androgen Receptor Pathway Inhibitor and a PARP Inhibitor for Metastatic Castration-resistant Prostate Cancer? The Answer Is No |
| 网址 | |
| DOI | |
| 其它 |
期刊:European Urology Focus 作者:Fred Saad 出版日期:2024-07-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)